BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 813569)

  • 1. Comparison of in vitro susceptibility of Neisseria gonorrhoeae to trimethoprim-sulfamethoxazole on three different media.
    Yoshikawa TT; Miyamoto S; Guze LB
    Antimicrob Agents Chemother; 1975 Nov; 8(5):515-7. PubMed ID: 813569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gonorrhea with trimethoprim-sulfamethoxazole.
    Elliott WC; Reynolds G; Thornsberry C; Kellogg DS; Jaffe HW; Brown ST; Armstrong J; Rein MF
    J Infect Dis; 1977 Jun; 135(6):939-43. PubMed ID: 405433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination.
    Marks MI; Kazemi M; MacKay E
    Antimicrob Agents Chemother; 1973 Nov; 4(5):555-9. PubMed ID: 4791490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression-line analysis of trimethoprim-sulfamethoxazole activity against Neisseria gonorrhoeae.
    Prior RB; Fass RJ; Perkins RL
    Am J Clin Pathol; 1976 Sep; 66(3):605-9. PubMed ID: 822707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sulfamethoxazole-trimethoprim synergistic action against members of the family Enterobacteriaceae with a two-plate agar dilution breakpoint MIC system.
    Ward PB; Carson M; Dodd JS; Pavillard ER
    J Clin Microbiol; 1984 Jun; 19(6):899-901. PubMed ID: 6381529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
    Wallace RJ; Wiss K; Bushby MB; Hollowell DC
    Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.
    Rein MF; Elliott WC; Swenson JM; Thornsberry C
    Antimicrob Agents Chemother; 1980 Feb; 17(2):247-50. PubMed ID: 6770754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of sulphamethoxazole by trimethoprim in Neisseria gonorrhoeae strains.
    Stolz E; Michel MF; Zwart HG
    Chemotherapy; 1977; 23(2):65-72. PubMed ID: 401723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single large dose of trimethoprim-sulfamethoxazole fails to cure gonococcal urethritis in men.
    Prior RB; Fass RJ; Perkins RL
    Sex Transm Dis; 1978; 5(2):62-4. PubMed ID: 10328033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the suitability of three common bacterial media for susceptibility testing of trimethoprim-sulfamethoxazole.
    Ferguson RW; Weissfeld AS
    J Clin Microbiol; 1984 Jan; 19(1):85-6. PubMed ID: 6418766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro resistance of Neisseria gonorrhoeae to metronidazole.
    Yoshikawa TT; Miyamoto S; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1974 Sep; 6(3):327-9. PubMed ID: 15830482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro susceptibility of 400 isolates of Neisseria gonorrhoeae in Vancouver, 1982-84.
    Bowie WR; Shaw CE; Chan DG; Jones HD; Black WA
    CMAJ; 1986 Sep; 135(5):489-93. PubMed ID: 3091234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Durban, South Africa.
    Coovadia YM; Kharsany A; Ramsaroop U
    Br J Vener Dis; 1984 Oct; 60(5):306-8. PubMed ID: 6091842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.